Website Header with Language Selector and Dropdowns
Watermark

Isometheptene Fumarate


Catalog Number: CL-IMP-10
CAS No.: NA
Mol.F: C9H19N : C4H4O4
Mol.W: 141.3 : 116.1
Inv. Status: Custom Synthesis

Chemical Name: (Z)-6-(Methylamino)hept-2-en-2-ol fumarate .

Country of Origin: India

Product Category: Isometheptane Impurities


Isometheptene Fumarate is identified by CAS No. NA and is chemically known as (Z)-6-(Methylamino)hept-2-en-2-ol fumarate .

Isometheptene Fumarate is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Isometheptane.

Page Keywords: Buy Isometheptene Fumarate | Purchase Isometheptene Fumarate | Isometheptene Fumarate suppliers | Isometheptene Fumarate manufacturers | Isometheptene Fumarate price | Isometheptene Fumarate Importer | Isometheptene Fumarate Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-IMP-08
CAS No: 110-93-0
Mol Wt: 126.2
Mol F: C8H14O
Inv. Status: Custom Synthesis
CAT No: CL-IMP-09
CAS No: 4730-22-7
Mol Wt: 130.2
Mol F: C8H18O
Inv. Status: Custom Synthesis
CAT No: CL-IMP-01
CAS No: 6168-86-1
Mol Wt: 141.3 : 36.5
Mol F: C9H19N : HCl
Inv. Status: Custom Synthesis
CAT No: CL-IMP-02
CAS No: 503-00-4
Mol Wt: 143.3
Mol F: C9H21N
Inv. Status: Custom Synthesis
CAT No: CL-IMP-06
CAS No: 17086-16-7
Mol Wt: 159.3 : 36.5
Mol F: C9H21NO : HCl
Inv. Status: Custom Synthesis
CAT No: CL-IMP-07
CAS No: 7492-31-1
Mol Wt: 141.3 : 1/2(210.0)
Mol F: C9H19N : 1/2(C6H10O8)
Inv. Status: Custom Synthesis
CAT No: CL-IMP-03
CAS No: 627-98-5
Mol Wt: 116.2
Mol F: C7H16O
Inv. Status: Custom Synthesis
CAT No: CL-IMP-04
CAS No: 1569-60-4
Mol Wt: 128.2
Mol F: C8H16O
Inv. Status: Custom Synthesis
CAT No: CL-IMP-05
CAS No: 764-32-9
Mol Wt: 112.2
Mol F: C7H12O
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.